![Christopher Slapak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Slapak
Geen lopende functies
Profiel
Christopher Slapak worked as Vice President-Early Phase Development Oncology at Eli Lilly & Co. from 1996 to 2017.
He also worked as an Assistant Professor at Dana-Farber Cancer Institute, Inc. and as an Associate Professor-Clinical at The Indiana University School of Medicine.
In 2018, he became the Chief Medical Officer at Prelude Therapeutics, Inc. and in 2020, he became the Chief Medical Officer at Vor Biopharma, Inc. Dr. Slapak received his undergraduate degree from The Ohio State University and his doctorate degree from Pritzker School of Medicine.
Eerdere bekende functies van Christopher Slapak
| Bedrijven | Functie | Einde |
|---|---|---|
| VOR BIOPHARMA INC. | Hoofd Techniek/Wetenschap/O&O | 06-05-2022 |
| PRELUDE THERAPEUTICS INCORPORATED | Hoofd Techniek/Wetenschap/O&O | 01-06-2019 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-12-2017 |
The Indiana University School of Medicine
 The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Corporate Officer/Principal | - |
Opleiding van Christopher Slapak
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
79
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Indiana University School of Medicine
The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
